
Fei Xu
Articles
-
Jan 8, 2025 |
science.org | Longji Zhu |Yunan Yang |Fei Xu |Xinyu Lu |XiaoMeng Chen |Hu Li | +8 more
Raman-OSDL can accurately identify pathogens in real-world air, avoiding interference from diverse indigenous bacteria.
-
Nov 26, 2024 |
mdpi.com | Fei Xu |Qing Xiao |William Du |Sheng Wang
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
-
Oct 8, 2024 |
pubs.rsc.org | Mingjin Cui |Ying Zhang |Bo Xu |Fei Xu
High-entropy alloy nanomaterials for electrocatalysis High-entropy alloys (HEAs) exhibit a remarkable capacity to modulate geometric and electronic structures for the construction of catalysts with unpredictable and exceptional performance, and have attracted substantial acclaim within the domain of materials science. In this comprehensive review, we present a thorough summary of the synthesis and multiple applications of HEAs in the realm of electrocatalysis.
-
Oct 6, 2024 |
mdpi.com | Yuwen Wang |Jie Chen |Fei Xu |Yuqi Xue
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
-
Jun 25, 2024 |
bmccancer.biomedcentral.com | Xin Hua |Fei Xu |Wei Shi |Xin Huang |Fang-Fang Duan |Si-Fen Wang | +7 more
Participants in this research included 858 patients with NPC who had platinum-based CCRT at the Sun Yat-sen University Cancer Center from January 2010 to December 2014. Table 1 provides an overview of the clinicopathological features at baseline. Notably, 638 (74.4%) of the total patients were male, while 220 (25.6%) were female, with 64 years being the median age (range: 18–84 years). There were 436 (50.8%) patients > 45 years old and 422 (49.2%) patients under the age of 45.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →